"Universal Research Group conducts and provides oversight and management of clinical research trials sponsored by Pharmaceutical companies for a variety of medical problems."

During the past decade, Universal Research Group, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universal Research Group, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "CardioKine Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universal Research Group, LLC" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Universal Research Group, LLC" are "Alzheimer Disease" (3 trials), "Cardiovascular Disease" (3 trials), "Type 2 Diabetes" (2 trials), "Alzheimer's Disease" (1 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "Universal Research Group, LLC" in a lesser frequency.

Most popular intervention types in "Universal Research Group, LLC" are "Drug" (16 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Donanemab" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Alum" (1 trials) and "BI 690517" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universal Research Group, LLC" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Universal Research Group, LLC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Universal Research Group, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universal Research Group, LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".